Zeng Wenhui, Wu Luyan, Sun Yidan, Wang Yuqi, Wang Jinfang, Ye Deju
State Key Laboratory of Analytical Chemistry for Life Science, Chemistry and Biomedicine Innovation Center (ChemBIC), School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, 210023, China.
Research Center of Resources and Environment, School of Chemical Engineering and Materials, Changzhou Institute of Technology, Changzhou, 213022, China.
Small. 2021 Sep;17(36):e2101924. doi: 10.1002/smll.202101924. Epub 2021 Jul 26.
Enzyme-activatable ratiometric near-infrared (NIR) fluorescent probes enabling noninvasive imaging of enzyme activity in vivo are promising for biomedical research; however, such probes with ratiometric fluorescence emissions both in NIR window under a single NIR light excitation are largely unexplored. Here, a quenched NIR fluorophore of Cy5.5 is integrated with NIR fluorescent poly[2,6-(4,4-bis-(2-ethylhexyl)-4H-cyclopenta[2,1-b;3,4-b']dithiophene)-alt-4,7(2,1,3-benzothiadiazole)] (PCPDTBT)-based semiconducting polymer nanoparticles (SPNs), and an α β integrin-targeting and matrix metalloproteinase-2 (MMP-2)-activatable ratiometric fluorescent probe (SPN-MMP-RGD) is developed. Under excitation at 660 nm, SPN-MMP-RGD shows "always-on" fluorescence of PCPDTBT (830 nm) and activatable fluorescence of Cy5.5 (690 nm) toward MMP-2, affording a remarkable ≈176-fold enhancement in fluorescence intensity ratio between 690 and 830 nm (I /I ) for sensitive detection of MMP-2 activity in vitro and in tumor cells. By virtue of ratiometric fluorescence imaging independently of probe's concentration, SPN-MMP-RGD can not only accurately report on MMP-2 levels regarding different tumor sizes, but also noninvasively delineate MMP-2-positive tiny gastric tumors metastasis in vivo. The authors' study reveals the potential of SPN-MMP-RGD for ratiometric fluorescence imaging of MMP-2 activity via combining two independent NIR fluorophores, which can be amenable for the design of other enzyme-activatable ratiometric NIR fluorescent probes for reliable in vivo imaging.
能够对体内酶活性进行无创成像的酶激活比率近红外(NIR)荧光探针在生物医学研究中具有广阔前景;然而,在单一近红外光激发下在近红外窗口具有比率荧光发射的此类探针在很大程度上尚未得到充分探索。在此,将淬灭的Cy5.5近红外荧光团与基于近红外荧光聚[2,6-(4,4-双-(2-乙基己基)-4H-环戊并[2,1-b;3,4-b']二噻吩)-交替-4,7(2,1,3-苯并噻二唑)](PCPDTBT)的半导体聚合物纳米颗粒(SPN)相结合,开发了一种αβ整合素靶向且基质金属蛋白酶-2(MMP-2)可激活的比率荧光探针(SPN-MMP-RGD)。在660nm激发下,SPN-MMP-RGD对MMP-2显示出PCPDTBT的“始终开启”荧光(830nm)和可激活的Cy5.5荧光(690nm),在690nm和830nm之间的荧光强度比(I /I )有显著的≈176倍增强,用于体外和肿瘤细胞中MMP-2活性的灵敏检测。借助与探针浓度无关的比率荧光成像,SPN-MMP-RGD不仅可以准确报告不同肿瘤大小的MMP-2水平,还能在体内无创描绘MMP-2阳性微小胃肿瘤转移情况。作者的研究揭示了SPN-MMP-RGD通过结合两种独立的近红外荧光团用于MMP-2活性比率荧光成像的潜力,这可适用于设计其他用于可靠体内成像的酶激活比率近红外荧光探针。